{"version":"1.0","type":"rich","provider_name":"Everlit","provider_url":"https://everlit.audio/","title":"Opinion: Why ending New Hampshire’s PDAB was the right move for patients","description":"New Hampshire has repealed its Prescription Drug Affordability Board, which was ineffective in lowering drug costs and added layers of bureaucracy, and other states should follow suit.","author_name":"Concord Monitor","thumbnail_url":"https://cdn.everlit.audio/covers/artl_1Pn5bCmn3Xa/72b93a69-d4ed-41a5-980c-748677a49dc7/small.webp","width":480,"height":136,"html":"\u003ciframe title=\"Opinion: Why ending New Hampshire’s PDAB was the right move for patients\" src=\"https://everlit.audio/embeds/artl_1Pn5bCmn3Xa\" width=\"100%\" height=\"136px\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen\u003e\u003c/iframe\u003e"}